학술논문

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL
Document Type
Article
Source
In: Blood. (Blood, 28 September 2023, 142(13):1131-1142)
Subject
Language
English
ISSN
15280020
00064971